John G Ullman & Associates Inc. Boosts Stake in Xylem Inc. (NYSE:XYL)

John G Ullman & Associates Inc. boosted its stake in Xylem Inc. (NYSE:XYL) by 9.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,580 shares of the industrial products company’s stock after purchasing an additional 220 shares during the period. John G Ullman & Associates Inc.’s holdings in Xylem were worth $348,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. Swedbank AB raised its holdings in shares of Xylem by 22.8% in the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock valued at $403,953,000 after buying an additional 554,609 shares during the period. Mirova US LLC increased its stake in Xylem by 2.0% during the second quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock worth $254,526,000 after purchasing an additional 36,013 shares during the period. Impax Asset Management Group plc lifted its position in shares of Xylem by 1.0% during the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock worth $226,555,000 after purchasing an additional 15,825 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its stake in shares of Xylem by 2.2% in the second quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after purchasing an additional 36,601 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in shares of Xylem by 9.3% in the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company’s stock valued at $219,731,000 after purchasing an additional 137,883 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 0.5 %

Shares of NYSE XYL opened at $122.84 on Thursday. The stock has a market cap of $29.84 billion, a PE ratio of 35.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.05. Xylem Inc. has a 52-week low of $100.46 and a 52-week high of $146.08. The business has a 50-day moving average price of $130.33 and a 200 day moving average price of $134.46. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. During the same period last year, the firm posted $0.99 earnings per share. The company’s revenue for the quarter was up .2% compared to the same quarter last year. Equities research analysts forecast that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.17%. Xylem’s payout ratio is 42.11%.

Analysts Set New Price Targets

XYL has been the subject of several recent research reports. Stifel Nicolaus raised their price target on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. TD Cowen decreased their target price on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Robert W. Baird cut their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. UBS Group initiated coverage on Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target on the stock. Finally, Royal Bank of Canada lowered their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $147.17.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.